Arvinas (NASDAQ:ARVN) Downgraded by Wedbush to Neutral
Arvinas (NASDAQ:ARVN – Get Free Report) was downgraded by analysts at Wedbush from an “outperform” rating to a “neutral” ...
Wedbush Has Optimistic Outlook of TSE:FRX FY2025 Earnings
Investment analysts at Wedbush boosted their FY2025 earnings estimates for shares of Fennec Pharmaceuticals in a research ...